CFTR and cystic fibrosis: A novel SNP on an F508del background, therefore, would not confer additional deleterious effects (F508del is already non-functional) and would be extremely unlikely to elicit positive selection in a CF carrier (the wt CFTR at this locus is already fully functional; i.e., there is no dominant negative effect).